{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:25:00Z","timestamp":1767968700851,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.forsciint.2019.109959","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T19:54:57Z","timestamp":1568318097000},"page":"109959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Organ distribution of diclazepam, pyrazolam and 3-fluorophenmetrazine"],"prefix":"10.1016","volume":"303","author":[{"given":"Sabrina","family":"Lehmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alissa","family":"Sczyslo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Froch-Cortis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus Alexander","family":"Rothschild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Thevis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8779-8902","authenticated-orcid":false,"given":"Hilke","family":"Andresen-Streichert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3843-9065","authenticated-orcid":false,"given":"Katja","family":"Mercer-Chalmers-Bender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2019.109959_bib0005","series-title":"World Drug Report 2018. Analysis of Drug Markets. Opiates, Cocaine, Cannabis, Synthetic Drugs","author":"United Nations Office on Drugs and Crime (UNODC)","year":"2018"},{"issue":"10","key":"10.1016\/j.forsciint.2019.109959_bib0010","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.addbeh.2013.05.008","article-title":"Treatment or \u201chigh\u201d: benzodiazepine use in patients on injectable heroin or oral opioids","volume":"38","author":"Vogel","year":"2013","journal-title":"Addict. Behav."},{"issue":"2","key":"10.1016\/j.forsciint.2019.109959_bib0015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s13181-018-0659-3","article-title":"Assessment of the availability, cost, and motivations for use over time of the new psychoactive substances\u2014benzodiazepines diclazepam, flubromazepam, and pyrazolam\u2014in the UK","volume":"14","author":"Abouchedid","year":"2018","journal-title":"J. Med. Toxicol."},{"issue":"1","key":"10.1016\/j.forsciint.2019.109959_bib0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/dta.2211","article-title":"The emergence of new psychoactive substance (NPS) benzodiazepines: a review","volume":"10","author":"Manchester","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2019.109959_bib0025","series-title":"European Drug Report 2018: Trends and Developments","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2018"},{"issue":"7-8","key":"10.1016\/j.forsciint.2019.109959_bib0030","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/dta.1628","article-title":"Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics","volume":"6","author":"Moosmann","year":"2014","journal-title":"Drug Test. Anal."},{"issue":"1","key":"10.1016\/j.forsciint.2019.109959_bib0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/15563650.2015.1112907","article-title":"Flubromazolam\u2013A new life-threatening designer benzodiazepine","volume":"54","author":"\u0141ukasik-G\u0142\u0119bocka","year":"2016","journal-title":"Clin. Toxicol."},{"issue":"6","key":"10.1016\/j.forsciint.2019.109959_bib0040","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4103\/0253-7613.144943","article-title":"A case of etizolam dependence","volume":"46","author":"Gupta","year":"2014","journal-title":"Indian J. Pharmacol."},{"issue":"2","key":"10.1016\/j.forsciint.2019.109959_bib0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jat\/bkv122","article-title":"ELISA detection of phenazepam, etizolam, pyrazolam, flubromazepam, diclazepam and delorazepam in blood using Immunalysis\u00ae Benzodiazepine Kit","volume":"40","author":"O\u2019Connor","year":"2015","journal-title":"J. Anal. Toxicol."},{"issue":"4","key":"10.1016\/j.forsciint.2019.109959_bib0050","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00414-017-1541-6","article-title":"Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer","volume":"131","author":"El Balkhi","year":"2017","journal-title":"Int. J. Legal Med."},{"issue":"9","key":"10.1016\/j.forsciint.2019.109959_bib0055","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/jat\/bky039","article-title":"A case study involving U-47700, diclazepam and flubromazepam\u2014application of retrospective analysis of HRMS data","volume":"42","author":"Partridge","year":"2018","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2019.109959_bib0060","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/dta.2391","article-title":"Mixed intoxication by the synthetic opioid U\u201047700 and the benzodiazepine flubromazepam with lethal outcome: pharmacokinetic data","volume":"10","author":"Koch","year":"2018","journal-title":"Drug Test. Anal."},{"issue":"1-3","key":"10.1016\/j.forsciint.2019.109959_bib0065","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.forsciint.2008.08.012","article-title":"Case report: Etizolam and its major metabolites in two unnatural death cases","volume":"182","author":"Nakamae","year":"2008","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2019.109959_bib0070","series-title":"EMCDDA\u2013Europol 2013 Annual Report on the Implementation of Council Decision 2005\/387\/JHA","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2013"},{"issue":"6","key":"10.1016\/j.forsciint.2019.109959_bib0075","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1124\/mol.54.6.1097","article-title":"The benzodiazepine binding pocket of recombinant \u03b11\u03b22\u03b32 \u03b3-aminobutyric acidA receptors: Relative orientation of ligands and amino acid side chains","volume":"54","author":"Sigel","year":"1998","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.forsciint.2019.109959_bib0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11419-013-0187-4","article-title":"Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine","volume":"31","author":"Moosmann","year":"2013","journal-title":"Forensic Toxicol."},{"issue":"11","key":"10.1016\/j.forsciint.2019.109959_bib0085","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1021\/jm00197a021","article-title":"6-Aryl-4H-s-triazolo [4, 3-a][1, 4] benzodiazepines. Influence of 1-substitution on pharmacological activity","volume":"22","author":"Hester","year":"1979","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.forsciint.2019.109959_bib0090","series-title":"EMCDDA\u2013Europol 2012 Annual Report on the Implementation of Council Decision 2005\/387\/JHA","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2012"},{"issue":"9","key":"10.1016\/j.forsciint.2019.109959_bib0095","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/15563650.2016.1211288","article-title":"Adverse events related to the new psychoactive substance 3-fluorophenmetrazine\u2013results from the Swedish STRIDA project","volume":"54","author":"B\u00e4ckberg","year":"2016","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.forsciint.2019.109959_bib0100","first-page":"418","article-title":"3-Fluorophenmetrazine\u2014a new psychoactive substance on the polish drug market","volume":"105","author":"Adamowicz","year":"2016","journal-title":"Problems Forensic Sci."},{"key":"10.1016\/j.forsciint.2019.109959_bib0105","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/dta.2577","article-title":"Method validation and preliminary pharmacokinetic studies on the new designer stimulant 3-fluorophenmetrazine (3-FPM)","volume":"11","author":"Grumann","year":"2019","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2019.109959_bib0110","first-page":"1","article-title":"Application of the QuEChERS procedure for analysis of \u0394 9-tetrahydrocannabinol and its metabolites in authentic whole blood samples by GC\u2013MS\/MS","author":"Dybowski","year":"2018","journal-title":"Forensic Toxicol."},{"issue":"1","key":"10.1016\/j.forsciint.2019.109959_bib0115","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/jat\/bkx080","article-title":"Toxicokinetics of the synthetic cathinone \u03b1-pyrrolidinohexanophenone","volume":"42","author":"Fujita","year":"2017","journal-title":"J. Anal. Toxicol."},{"issue":"1","key":"10.1016\/j.forsciint.2019.109959_bib0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11419-014-0245-6","article-title":"Postmortem distribution of AB-CHMINACA, 5-fluoro-AMB, and diphenidine in body fluids and solid tissues in a fatal poisoning case: usefulness of adipose tissue for detection of the drugs in unchanged forms","volume":"33","author":"Hasegawa","year":"2015","journal-title":"Forensic Toxicol."},{"issue":"5","key":"10.1016\/j.forsciint.2019.109959_bib0125","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.legalmed.2015.06.005","article-title":"A fatal case of poisoning related to new cathinone designer drugs, 4-methoxy PV8, PV9, and 4-methoxy PV9, and a dissociative agent, diphenidine","volume":"17","author":"Kudo","year":"2015","journal-title":"Legal Med. Tokyo"},{"issue":"2","key":"10.1016\/j.forsciint.2019.109959_bib0130","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s11419-018-0408-y","article-title":"Organ distribution of 4-MEC, MDPV, methoxetamine and \u03b1-PVP: comparison of QuEChERS and SPE","volume":"36","author":"Lehmann","year":"2018","journal-title":"Forensic Toxicol."},{"issue":"5","key":"10.1016\/j.forsciint.2019.109959_bib0135","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/jat\/bky006","article-title":"Quantification of 15 psychotropic drugs in serum and postmortem blood samples after a modified mini-QuEChERS by UHPLC\u2013MS-MS","volume":"42","author":"Pouliopoulos","year":"2018","journal-title":"J. Anal. Toxicol."},{"issue":"3","key":"10.1016\/j.forsciint.2019.109959_bib0140","first-page":"81","article-title":"Comparison of the modified QuEChERS method and the conventional method of extraction in forensic medicine to detect methadone in post-mortem urine by GCMS","volume":"6","author":"Salimiasl","year":"2017","journal-title":"APJMT"},{"issue":"6","key":"10.1016\/j.forsciint.2019.109959_bib0145","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.legalmed.2012.04.008","article-title":"Rapid drug extraction from human whole blood using a modified QuEChERS extraction method","volume":"14","author":"Usui","year":"2012","journal-title":"Legal Med. Tokyo"},{"key":"10.1016\/j.forsciint.2019.109959_bib0150","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/dta.2390","article-title":"Direct detection of the psychoactive substance MT\u201045 in human tissue samples by probe electrospray ionization\u2010tandem mass spectrometry","volume":"10","author":"Usui","year":"2018","journal-title":"Drug Test. Anal."},{"issue":"6","key":"10.1016\/j.forsciint.2019.109959_bib0155","first-page":"509","article-title":"QuEChERS extraction of benzodiazepines in biological matrices","volume":"3","author":"Westland","year":"2013","journal-title":"JPA"},{"key":"10.1016\/j.forsciint.2019.109959_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vascn.2017.10.001","article-title":"Comparison of efficiencies of selected sample extraction techniques for the analysis of selected antiretroviral drugs in human plasma using LC-MS","volume":"89","author":"Sichilongo","year":"2018","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"2","key":"10.1016\/j.forsciint.2019.109959_bib0165","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.forsciint.2006.05.021","article-title":"Validation of new methods","volume":"165","author":"Peters","year":"2007","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2019.109959_bib0170","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11419-017-0355-z","article-title":"Analysis of taxine B\/isotaxine B in a plasma specimen by LC\u2013MS\/MS in a case of fatal poisoning: concealed suicide by ingestion of yew (Taxus L.) leaves of a patient with a long-term history of borderline personality disorder","volume":"35","author":"Gaunitz","year":"2017","journal-title":"Forensic Toxicol."},{"issue":"11","key":"10.1016\/j.forsciint.2019.109959_bib0175","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1515\/CCLM.2004.251","article-title":"Systematic toxicological analysis by high-performance liquid chromatography with diode array detection (HPLC-DAD)","volume":"42","author":"Pragst","year":"2004","journal-title":"Clin. Chem. Lab. Med."},{"issue":"4","key":"10.1016\/j.forsciint.2019.109959_bib0180","doi-asserted-by":"crossref","first-page":"R136","DOI":"10.1186\/cc11441","article-title":"Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics","volume":"16","author":"Schulz","year":"2012","journal-title":"Crit. Care"},{"key":"10.1016\/j.forsciint.2019.109959_bib0185","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jchromb.2017.09.003","article-title":"Determination of 74 new psychoactive substances in serum using automated in-line solid-phase extraction-liquid chromatography-tandem mass spectrometry","volume":"1064","author":"Lehmann","year":"2017","journal-title":"J. Chromatogr. B"},{"issue":"3","key":"10.1016\/j.forsciint.2019.109959_bib0190","first-page":"142","article-title":"Richtlinie der GTFCh zur Qualit\u00e4tssicherung bei forensisch-toxikologischen Untersuchungen","volume":"76","author":"Paul","year":"2009","journal-title":"Toxichem. Krimtech."},{"issue":"5","key":"10.1016\/j.forsciint.2019.109959_bib0195","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/clpt.1980.220","article-title":"Kinetics and biotransformation of lormetazepam: II. Radioimmunologic determinations in plasma and urine of young and elderly subjects: First-pass effect","volume":"28","author":"H\u00fcmpel","year":"1980","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.forsciint.2019.109959_bib0200","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.forsciint.2016.09.006","article-title":"Blood concentrations of new designer benzodiazepines in forensic cases","volume":"268","author":"H\u00f8iseth","year":"2016","journal-title":"Forensic Sci. Int."},{"issue":"1","key":"10.1016\/j.forsciint.2019.109959_bib0205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use","volume":"18","author":"Barker","year":"2004","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.forsciint.2019.109959_bib0210","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"10.1016\/j.forsciint.2019.109959_bib0215","first-page":"233","article-title":"Postmortem redistribution of triazolam, alprazolam, delorazepam (chlordesmethyldiazepam) and zolpidem in a suicide case","volume":"27","author":"Gerace","year":"2015","journal-title":"Toxicol. Anal. Clin."},{"issue":"9","key":"10.1016\/j.forsciint.2019.109959_bib0220","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jat\/bkx060","article-title":"Multiple drug-toxicity involving novel psychoactive substances, 3-fluorophenmetrazine and U-47700","volume":"41","author":"Ellefsen","year":"2017","journal-title":"J. Anal. Toxicol."},{"issue":"4","key":"10.1016\/j.forsciint.2019.109959_bib0225","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00414-012-0671-0","article-title":"Isomers of fluoroamphetamines detected in forensic cases in Denmark","volume":"126","author":"Johansen","year":"2012","journal-title":"Int. J. Legal Med."},{"issue":"8","key":"10.1016\/j.forsciint.2019.109959_bib0230","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jat\/27.8.533","article-title":"Mechanisms underlying postmortem redistribution of drugs: a review","volume":"27","author":"P\u00e9lissier-Alicot","year":"2003","journal-title":"J. Anal. Toxicol."},{"issue":"4","key":"10.1016\/j.forsciint.2019.109959_bib0235","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2125.2008.03231.x","article-title":"Post-mortem clinical pharmacology","volume":"66","author":"Ferner","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.forsciint.2019.109959_bib0240","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.forsciint.2004.02.012","article-title":"Preanalytic aspects in postmortem toxicology","volume":"142","author":"Skopp","year":"2004","journal-title":"Forensic Sci. Int."},{"issue":"3","key":"10.1016\/j.forsciint.2019.109959_bib0245","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1445-5994.2009.02111.x","article-title":"Post-mortem drug concentrations","volume":"40","author":"Kennedy","year":"2010","journal-title":"Int. Med. J."},{"issue":"1-3","key":"10.1016\/j.forsciint.2019.109959_bib0250","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.forsciint.2012.01.016","article-title":"Evaluation of postmortem redistribution phenomena for commonly encountered drugs","volume":"219","author":"Han","year":"2012","journal-title":"Forensic Sci. Int."},{"issue":"2","key":"10.1016\/j.forsciint.2019.109959_bib0255","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/00085030.1995.10757474","article-title":"A comparison of drug concentrations in postmortem cardiac and peripheral blood in 320 cases","volume":"28","author":"Dalpe-Scott","year":"1995","journal-title":"Can. Soc. Forensic Sci. J."},{"issue":"3-4","key":"10.1016\/j.forsciint.2019.109959_bib0260","first-page":"265","article-title":"Effects of liver disease on the pharmacokinetics of intravenous and oral chlordesmethyldiazepam","volume":"48","author":"Bareggi","year":"1995","journal-title":"Eur. J. Clin. Pharmacol."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073819303718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073819303718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T17:57:03Z","timestamp":1759946223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073819303718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":52,"alternative-id":["S0379073819303718"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2019.109959","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organ distribution of diclazepam, pyrazolam and 3-fluorophenmetrazine","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2019.109959","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109959"}}